Literature DB >> 31604064

Role of miRNA sponges in hepatocellular carcinoma.

Dandan Li1, Jiawei Zhang1, Jinming Li2.   

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. HCC patients are commonly diagnosed at an advanced stage, for which highly effective therapies are limited. Hence, there is a growing need to discover promising biomarkers for HCC diagnosis, and in this context, microRNAs (miRNAs) hold great promise. MiRNAs function as gene expression regulators by directly binding messenger RNAs (mRNAs) and subsequently causing suppression of mRNA translation or degradation of target mRNAs. Two major types of noncoding RNAs act as competing endogenous sponges: circular RNAs and long non-coding RNAs.They can competitively bind to miRNA through miRNA response elements (MREs), thereby reducing the number of miRNAs binding mRNAs and regulating the expression of downstream target genes of miRNAs at the posttranscriptional level. The relationship between single miRNA sponge and HCC has been explored. However, comprehensive reviews on the sponge's function in HCC are lacking. In this review, we describe the methods to find endogenous sponges and construct exogenous sponges, and briefly compare endogenous and exogenous sponges. We also summarize the current progress on the functional role of miRNA sponges in HCC pathogenesis and present their potential value as diagnostic biomarkers and therapeutic targets. In-depth investigations on the function and mechanism of miRNA sponges in HCC will enrich our knowledge of HCC pathogenesis and contribute to the development of effective diagnostic biomarkers and therapeutic targets for HCC.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnostic biomarker; HCC; Therapeutic target; miRNA sponge

Mesh:

Substances:

Year:  2019        PMID: 31604064     DOI: 10.1016/j.cca.2019.09.013

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  30 in total

1.  [High expression of miR-3682-3p is an unfavorable prognostic factor of hepatocellular carcinoma].

Authors:  S Liu; Y Wen; B Quan; J Lin; Z Zhu; J Tang; S Han
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-12-20

2.  miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.

Authors:  Da Teng; Shaoyou Xia; Shidong Hu; Yang Yan; Boyan Liu; Yu Yang; Xiaohui Du
Journal:  Comput Intell Neurosci       Date:  2022-06-27

3.  LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940.

Authors:  Yingying Zhang; Hongyu Zhang; Shuhuan Wu
Journal:  J Hepatocell Carcinoma       Date:  2021-05-03

4.  miR-4999-5p Predicts Colorectal Cancer Survival Outcome and Reprograms Glucose Metabolism by Targeting PRKAA2.

Authors:  Qiwei Zhang; Zhi Hong; Jieyao Zhu; Chao Zeng; Zhen Tang; Weiqiang Wang; He Huang
Journal:  Onco Targets Ther       Date:  2020-02-11       Impact factor: 4.147

5.  Circ_LDLR Knockdown Suppresses Progression of Hepatocellular Carcinoma via Modulating miR-7/RNF38 Axis.

Authors:  Yuming Jia; Shengchao Li; Meng Zhang; Zhilei Zhang; Chao Wang; Chong Zhang; Wuhan Yang; Li Peng; Zhuo Xu
Journal:  Cancer Manag Res       Date:  2021-01-13       Impact factor: 3.989

6.  The Effects of Naringenin on miRNA-mRNA Profiles in HepaRG Cells.

Authors:  Weiyang Fan; Rui Shi; Minyi Guan; Pan Chen; Hao Wu; Weiwei Su; Yonggang Wang; Peibo Li
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

7.  hsa_circ_0060975 is highly expressed and predicts a poor prognosis in gastric cancer.

Authors:  Peng Xu; Xiaolan Xu; Lixiang Zhang; Zhengnan Li; Jianjun Qiang; Jie Yao; Aman Xu
Journal:  Oncol Lett       Date:  2021-06-24       Impact factor: 2.967

8.  Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1.

Authors:  Jing Yang; Bo Li; Shuo Zhao; Hongyu Du; Yaming Du
Journal:  Onco Targets Ther       Date:  2020-07-07       Impact factor: 4.147

9.  LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.

Authors:  Xue-Zhen Song; Xiao-Ning Ren; Xiao-Jun Xu; Xiao-Xuan Ruan; Yi-Li Wang; Ting-Ting Yao
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.

Authors:  Hui He; Yawei Wang; Peng Ye; Dehui Yi; Ying Cheng; Haibo Tang; Zhi Zhu; Xun Wang; Shi Jin
Journal:  J Exp Clin Cancer Res       Date:  2020-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.